We are live on ! Find out more
DCMIC

Decheng Capital Management III (Cayman) Portfolio holdings

AUM $300M
1-Year Est. Return 15.74%
This Fund
S&P 500
This Quarter Est. Return
+9.76%
1 Year Est. Return
+15.74%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$267M
AUM Growth
-$8.62M
Cap. Flow
-$4.02M
Cap. Flow %
-1.5%
Top 10 Hldgs %
80.22%
Holding
28
New
2
Increased
1
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
ALP.PRN
Alabama Power Co 5.20% CL-A PRF
ALP.PRN
+$49.3M
2
AURA icon
Aura Biosciences
AURA
+$1.06M

Top Sells

Rank Stock Value
1
ALPN
Alpine Immune Sciences Inc
ALPN
+$48.3M
2
ILMN icon
Illumina
ILMN
+$10.5M
3
BYSI icon
BeyondSpring
BYSI
+$4.91M

Sector Composition

Rank Sector Weight
1 Healthcare 77.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALPN
26
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-6,708,288
Closed -$48.3M
1
2

Similar funds

IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
DT
Daniels + Tansey Wilmington, Delaware $289M AUM 18.06% 1-Year Est. Return
SFG
Steward Financial Group Colleyville, Texas $315M AUM 13.78% 1-Year Est. Return
TFA
Triad Financial Advisors Greensboro, North Carolina $284M AUM 14.95% 1-Year Est. Return
AEPLI
AH Equity Partners LSV I Menlo Park, California $315M AUM 9.31% 1-Year Est. Return
CC
Chanos & Company New York $318M AUM 4.62% 1-Year Est. Return
KBC
Key Bridge Compliance $319M AUM

Decheng Capital Management III (Cayman)'s Q4 2022 Portfolio in Review

As of Q4 2022, Decheng Capital Management III (Cayman) held 28 positions worth $267M, down 3.1% from $276M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Decheng Capital Management III (Cayman)'s Q4 2022 filing shows 2 new, 1 increased, 1 reduced and 2 closed positions. Its largest new stake was Alabama Power Co 5.20% CL-A PRF: 6,708,288 shares worth $49.3M. The largest sale was Alpine Immune Sciences Inc, an estimated $48.3M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 99% a quarter earlier.

  • Decheng Capital Management III (Cayman)'s largest Q4 2022 buy was Alabama Power Co 5.20% CL-A PRF: 6,708,288 shares worth $49.3M.
  • Decheng Capital Management III (Cayman) added most to Aura Biosciences in Q4 2022, an estimated $1.06M increase.
  • Decheng Capital Management III (Cayman)'s biggest Q4 2022 reduction was Illumina, cutting an estimated $10.5M.
  • Decheng Capital Management III (Cayman) fully exited Alpine Immune Sciences Inc in Q4 2022, selling an estimated $48.3M.
  • Decheng Capital Management III (Cayman)'s ten largest holdings make up 80% of its $267M portfolio in Q4 2022.
  • Decheng Capital Management III (Cayman) opened 2 new positions and closed 2 in Q4 2022.
  • Decheng Capital Management III (Cayman)'s portfolio value fell 3.1% quarter-over-quarter to $267M.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q4 2022, filed 9 Feb 2023.